Configuration and expression of the T cell receptor beta chain gene in human T-lymphotrophic virus I-infected cells by unknown
CONFIGURATION  AND  EXPRESSION  OF  THE  T  CELL 
RECEPTOR  /3  CHAIN  GENE  IN  HUMAN 
T-LYMPHOTROPHIC  VIRUS  I-INFECTED  CELLS 
BY RUTH F. JARRETT,*  HIROAKI MITSUYA,  ~ DEAN  L. MANN,* 
JEFFREY COSSMAN, ~ SAMUEL BRODER,  § AND  MARVIN S. REITZ* 
From the *Laboratory of Tumor Cell Biology, the *Division of Cancer Biology and Diagnosis, 
§The Clinical Oncology Program, and the u  Laboratory of Pathology, National Cancer Institute, 
Bethesda, Maryland 20205 
The human  T  cell leukemia/lymphotropic  virus type I  (HTLV-I) 1 is a  retro- 
virus etiologically associated with adult T  cell leukemia]lymphoma (ATLL) (1). 
ATLL has an aggressive clinical course and is often accompanied by opportunistic 
infections (2,  3).  Leukemic cells from patients are usually T3,T4 + and T8- (4); 
they express IL-2-R and class II  HLA (5).  This surface phenotype corresponds 
to that of mature helper/inducer cells that are immunologically activated (6-8). 
Cell lines derived from the leukemic cells, and cells infected by HTLV-I in vitro, 
generally have a similar phenotype (9,  10). 
Various abnormalities of immune function are demonstrable in the neoplastic 
cells from ATLL patients and in cell lines infected by HTLV-I.  Although  the 
leukemic cells have the surface phenotype of helper cells, they do not manifest 
helper  activity,  and  some  function  as  suppressor  cells  (5).  Cloned  T  cells  of 
known antigen specificity that have been infected by HTLV-I in vitro show loss 
of the ability to respond to specific antigen; both helper and cytotoxic functions 
may be inhibited (11-14). Some T  cells infected by HTLV-I in vitro have been 
shown to respond  to antigen  without the requirement  for accessory cells (12). 
However,  with  time  in  culture,  they  also  became  nonresponsive  to  antigen. 
Despite the impairment of antigen-specific responsiveness, some cell lines infected 
by  HTLV-I  possess  the  ability  to  react  nondiscriminatively  to  HLA  class  II 
antigens (15). 
Patients  hospitalized  with  specific infectious diseases in  an  area  of Japan  in 
which  HTLV-I  is  endemic  were  found  to  have  an  almost  threefold  higher 
incidence  of antibodies  to  HTLV-I  than  the  general  population  (16).  This 
suggests  that  immune  dysfunction  may also  be an  important  consequence  of 
HTLV-I infection in the clinical situation. 
T  lymphocytes, unlike B lymphocytes, recognize foreign antigen in association 
with self HLA molecules (17). The T  cell receptor (TCR), which is thought to 
recognize  both  antigen  and  HLA  determinants  (18-20),  has  recently  been 
identified  as  a  90  kD  surface  glycoprotein  (21-25).  It  is  composed  of two 
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disulfide-linked peptides, an a  chain of 49-53 kD, and/3 chain of 43 kD. These 
are distinct from, but related to, Ig H  and L chains (26, 27). The TCR is present 
on the surface of T  cells, and is noncovalently associated with the T3 complex 
of glycoproteins (21-24, 28). 
Extensive molecular characterization of the gene encoding the/3 chain of the 
TCR  (TCR/3),  in  both  mouse  and  man,  has  revealed  that  it  is  composed  of 
separate V, D, J, and C region gene segments (29-39).  In germline DNA, there 
is an unknown number of V and D  regions; there are two tandemly arranged C 
region gene segments (Cfll and C/32), each preceeded by a cluster of  J  segments. 
During T  cell ontogeny, single V, D, andJ segments undergo somatic rearrange- 
ment to form a  functional gene.  This is analogous to the rearrangement of Ig 
genes  in  B  cells  (40).  Rearrangement  is  evident  at  stage  II  of  intrathymic 
development, when cells are T3-, T4  +, T6  +, and T8  +, but not at an earlier stage 
of ontogeny (41). The TCR/3 gene encodes a  1.3 kb mRNA transcript, which is 
present at  relatively high  levels during  intrathymic development and at  much 
lower levels in  mature,  peripheral  blood T  cells (29,  42).  A  truncated  1.0  kb 
mRNA  found  mainly in  immature thymocytes and  lacking a  V  region,  is also 
sometimes transcribed (43). The significance of this transcript is unclear, and a 
translation product has not been identified. 
We investigated the impairment of immune function in HTLV-I-infected cells 
and the possible role of the TCR in transformation by HTLV-I by addressing 
several questions. (a) Is there a  restricted number of TCRI3 gene configurations 
common to all  HTLV-I-infected cells? (b)  Does HTLV-I infection significantly 
alter the  level of expression of the TCR/3 gene at  the  mRNA  level? (c)  Is  the 
pattern  of rearrangement  or  level  of expression  of  the  TCR/3  gene  altered 
following infection by HTLV-I in vitro? (d) Is the TCRI3 gene configuration the 
same in primary leukemic cells as in the cell lines that are subsequently established 
in culture? 
Materials and  Methods 
Sources of Cells.  HUT  102 (44),  MJ (9),  UK 69 (45), W4489, WA (9), SD-line (46), 
and SK-line (9) are all HTLV-I-producing human T  cell lines derived from the leukemic 
cells  of patients  with  ATLL.  C91/PL  is  an  HTLV-I-infected cell  line  established  by 
cocultivation of umbilical cord blood cells with x-irradiated infected cells (9). HUT 78 is 
an  HTLV-I- human  neoplastic T  cell line that has a  similar surface phenotype to the 
HTLV-I  ÷ T  cell lines (47). CCRF-CEM and RPMI 8402 are HTLV-I- human T cell lines 
tbat have phenotypic markers typical of less mature T  cells (48).  CR-B (49), CF-B, and 
RPMI 8392 (48) are EBV-transformed B cell lines that are not infected by HTLV-I. CF- 
2 and HLS-line are cell lines, established from the peripheral blood of two patients with 
ATLL, which express B cell antigens and IgL chains (K on CF-2 and ~, on HLS-line) (50). 
Both cell lines contain integrated HTLV-I proviral sequences and express EBV nuclear 
antigen. CR-B and CF-B are from the same donors as the HUT 102 and CF-2 cell lines, 
respectively. 
F9164,  CF-fresh,  HLS-fresh, SD-fresh, and  SK-fresh are  primary tumor cells  from 
ATEL patients, which were obtained as described previously (51).  Fresh normal human 
lymphocytes were obtained from peripheral blood using Lymphocyte Separation Medium 
(Litton Bionetics Inc., Kensington, MD) and were cultured for 5 d in complete medium 
(RPMI 1640 supplemented with 4 mM L-glutamine, 5 ×  10  -5 M 2ME, 50 U/ml penicillin, 
and 50 tLg/ml streptomycin) with 10% FCS and a 1:1,000 dilution of PHA in the presence 
of IL-2 (lectin-depleted; Cellular Products, Inc., Buffalo, NY). JARRETT ET  AL.  385 
Generation of Antigen-specific Helper-inducer Clones.  YTA1, TM3,  and  TM5 are im- 
munologically competent cloned T  cells of helper-inducer pbenotype, which are specific 
for tetanus toxoid. They were infected in  vitro by cocultivation with lethally irradiated 
HTLV-I-producing tumor  cells,  and  subsequently  designated  YTA1-H,  TM3-H,  and 
TM5-H, respectively. YTAI and YTA1-H have been described elsewhere (I 2). Clones 
TM3  and  TM5  were  generated  in  a  similar  manner.  Briefly,  I0  n peripheral  blood 
mononuclear cells (PBMC)  isolated from heparinized blood of a normal volunteer (who 
had been immunized with tetanus toxoid and whose serum was negative for antibodies to 
HTLV-I) were cultured with 2 limit flocculation units (Lf) per milliliter  of tetanus toxoid 
(Commonwealth of Massachusetts  Department of Public Health, Jamaica Plain,  MA)  in 
24-well  microculture plates  (Costar,  Cambridge,  MA) at  37°C  in  5%  CO2-containing 
humidified air in  1 ml of complete media containing 10% autologous plasma.  After 7 d 
in culture, the cells were restimulated with the same concentration of tetanus toxoid plus 
irradiated  (4,000 rad) fresh autologous PBMC.  On day  14 and beyond, the cells  were 
exposed to 15% IL-2, and 15% FCS was substituted for the autoiogous plasma.  The cells 
were restimulated  every 7 d  as  described above.  On day 40 in culture,  the cells  were 
cloned by limiting dilution. The most rapidly growing clones (TM3, TM5), which were 
from wells plated with 0.5 cells/well,  were expanded with 15% IL-2-containing media and 
subjected to this study. 
Nucleic Acid Analysis.  High  molecular weight DNA was extracted as previously de- 
scribed (52). For Southern blots,  10-20 #g of DNA were digested for 15 h at 37°C with 
2  U/#g of the  restriction  endonuclease  Barn  HI,  Hind  III, or  Eco  RI  (International 
Biotechnologies, Inc.,  New  Haven,  CT);  where possible,  all  three enzymes were  used. 
The digestions were subjected to electrophoresis overnight at 35 V in 0.8% agarose, and 
transferred to nitrocellulose. They were subsequently hybridized for 15 h at 37°C in 50% 
formamide/0.45  M  NaCI with  a  ~2p-nick-translated  probe.  After hybridization,  filters 
were washed extensively with 0.5X SSC,  0.1%  SDS  at 65°C (Ix SSC  is 0.15  M  NaCI, 
0.015  M sodium citrate,  pH  7).  Hybrid bands were detected by autoradiography with 
Kodak AR film in a cassette using a Dupont Quanta IlI screen. 
Total  cellular  RNA  was  extracted  by  the  guanidine  isothiocyanate procedure  and 
further purified by oligodeoxythymidylic acid cellulose  chromatography (53).  Northern 
blot analyses were performed as described previously (54).  Dot blots were performed as 
previously described  using total cellular  RNA, which was quantitated  by hybridization 
with  the excised insert from the HLA class  I cDNA clone, pDPO (51).  Northern blots 
and dot blots were washed first with 2X SSC, 0.1% SDS at room temperature, then with 
0.1 x  SSC, 0.1% SDS at 42 °C, dried, and autoradiographed as for the Southern blots. 
The plasmid  YTJ2 was kindly provided by Dr.  Tak  Mak,  Ontario Cancer Institute, 
Toronto, Canada. This is a cDNA clone, in pBR322, of the TCR/3 gene isolated from the 
T  cell  line Jurkat.  It corresponds to nucleotides  100-870 of the published sequence of 
clone YT35 and includes V and C region sequences (29). The cloned insert was excised 
with  Pst  I and purified, using DEAE membrane NA45 (Schleicher and Schuell, Keene, 
NH), for use as probe. 
Analysis of Surface Antigens  by  mAb.  Phenotypic analysis  was  performed  by  using 
indirect immunofluorescence with a FACS (FACS II; Becton-Dickinson Immunocytometry 
Systems,  Sunnyvale, CA), as previously described (55).  Briefly,  cells were incubated with 
mAb (50-200 ng of antibody to 2 X 10 "~ cells), then washed and treated with an affinity- 
purified fluorescein-conjugated IgG fraction of goat anti-mouse IgG (whole molecular; 
Sigma Chemical Co., St.  Louis, MO).  Control staining with nonreactive mouse ascites at 
the equivalent protein concentration was consistently negative. The cells were tested with 
the following antibodies;  OKT3, OKT4, OKT8 (Ortho Pharmaceuticals,  Raritan,  N  J), 
HLA-DR (Becton-Dickinson  Immunocytometry Systems),  and  anti-Tac,  an  mAb  that 
reacts with  an epitope on or closely  linked to the IL-2-R (7). The relative expression of 
certain surface antigens was compared by median fluorescence intensity (channel number). 
The value obtained for infected cells was divided by that of uninfected cells; the resultant 
ratio defines the relative difference, in T3 or T4 antigen expression, between the infected 
and uninfected cells. 386  T  CELL  RECEPTOR  fl  CHAIN  IN  HTLV-I-INFECTED  CELLS 
FIGURE  1.  Configuration  of the TCRfl gene in  HTLV-I-infected cell lines.  20  t~g of the 
indicated  DNA were  digested  with  Eco  R1  (a)  or  Hind  III  (b)  and  analyzed  by  Southern 
blotting using the TCRfl gene clone YTJ2 insert as probe. The DNA was from CR-B, showing 
the germline configuration of the TCRfl gene (lane A),  HUT  102  (B), MJ (C), UK 69  (D), 
W4489 (E), and WA (F). 
Results 
The configuration of the TCRfl gene was studied by Southern blot analysis in 
31 cell lines and fresh leukemic cells infected by HTLV-I. Infection by HTLV-I 
was confirmed  in all  cases by Southern  or  Northern  blot analysis using a  full- 
length proviral clone as probe. Fig. 1, which shows the arrangement of the TCRfl 
gene  in  five  representative  HTLV-I-infected  cell  lines,  illustrates  the  main 
features seen in all Southern  blots.  Hybridization of DNA from the B cell line 
CR-B after digestion with  Eco  RI, and  labelling  with the TCRfl probe reveals 
four bands.  The band at  11.5  kb contains the Cfll  gene segment,  whereas the 
band at 4 kb spans the Cfl2 gene segment (39). Bands at 5 kb and 2.3 kb represent 
hybridization  with V  gene segments.  This pattern  of bands is characteristic  of 
the germline arrangement  of the TCRfl gene.  In the five HTLV-I-infected cell 
lines shown here, the  11.5 kb fragment is lost after digestion with Eco RI. This 
indicates  that  both  copies  of the  Cfll  segment  have  either  been  deleted  or 
rearranged  in these cell lines (assuming no chromosomal loss).  In Fig.  1, lane B, 
with DNA from HUT  102, a doublet, consisting of fragments of 9.4 and 8.6 kb 
is seen in  addition  to  the  remaining  germline  bands;  similarly  in  lane  C,  with 
DNA from M  J, two additional bands, again comprising a doublet, are seen. This 
is consistent with rearrangement  of both alleles of the TCRfl gene, and suggests 
that these rearrangements  have used the Cfll  gene segment.  In Fig.  1, lane D, 
showing  DNA  from  UK  69,  a  single  rearranged  band  is  seen,  and  there  is 
complete absence of the 11.5 kb germline fragment.  In lanes E and F, with DNA 
from W4489 and WA, respectively, the predominant bands remaining are those 
representing  hybridization  with  V  region  gene  segments  and  the  fragment 
spanning the Cfl2 gene segment. This implies that rearrangement  of the TCRfl 
gene in these cell lines has involved complete deletion of the Cfll gene segment 
and use of the C/32 gene segment.  In Fig.  1, lane E, two faint bands are seen at 
10 and 8 kb, indicating that not all of the cells within the cell line have the same JARRETT  ET  AL.  387 
FIGURE 2.  Expression of TCRI3 gene RNA in HTLV-I-infected cell lines. (a) Twofold serial 
dilutions of the RNA solutions were subjected to dot blot analysis using the 3~P-nick-translated 
probe YTJ2 insert. RNA was quantitated  relative to hybridization with the HLA class I gene 
pDPO. The RNA was from HUT 78 (lane A), CR-B as a negative control (B), PHA-stimulated 
lymphocytes (C), HUT 102 (D), MJ (E), and CEM (F). (b)  10 #g of the  indicated poly(A)  ÷- 
selected  RNA  were  subjected  to  Northern  blot  analysis using  YTJ2  insert  as  probe.  (c) 
Hybridization of the probe pDPO insert to the 1.6 kb HLA class I mRNA was used to estimate 
the amount of RNA on the filter shown in b. RNA was from RPMI 8402 as a positive control 
(lane G), RPMI 8392 as a negative control (H), HUT 102 (/), MJ (J), and C91/PL (K). The 
faint, lower band in c, lane G represents residual hydridization to the TCRB mRNA. 
rearrangement, and suggesting that this is not a  clonal population of cells.  One 
cannot  exclude  the  possibility,  however,  that  the  cell  line  was  derived  from a 
cional population of T  cells in which further rearrangements of the TCR/3 gene 
occurred with time in culture. 
Fig.  I b  shows  DNA  from  the  same  cell  lines  digested  with  the  restriction 
enzyme  Hind  [II.  In  the  germline  configuration,  the  fragment  at  -7.6  kb 
represents  hybridization  with  the  5'  part  of the  C/32  gene  segment  (39).  The 
pattern of bands seen in  lane C of Fig.  1 b, showing  DNA from MJ, is the same 
as that of the germline configuration, indicating that TCR/3 gene rearrangement 
is not detectable in  DNA from this cell line when cleaved by Hind III. In all the 
other  cell  lines  shown,  additional  fragments are seen,  implying rearrangement 
of the  TCR/3 gene.  In Fig.  1 b,  lane F,  there  is complete absence of the  7.6  kb 
fragment,  supporting  the  interpretation  that  rearrangement  of both  alleles,  in 
this example, involves the C/32  gene segment.  In all the cell lines illustrated,  the 
TCR/3  gene  is  rearranged,  and  in  each  case  the  rearrangement  is  distinct; 
furthermore,  the  C/31 and  C/32  segments  appear  to  be  used  at  roughly  equal 
frequencies. 
To determine  whether  the  level of transcription  or the  nature  of the  TCR/3 
gene message is altered in HTLV-I-infected cells, we compared cell lines infected 
by  HTLV-I  with  non-HTLV-I-infected  leukemic  cell  lines  and  with  PHA- 
stimulated  lymphocytes.  Levels of expression  of the  TCR/3  mRNA  were  com- 
pared  by dot  blot analysis (Fig.  2a).  The  HTLV-I-infected cell  lines  HUT102 
and MJ express levels of TCR/3 RNA comparable to or slightly lower than PHA- 
stimulated lymphocytes and substantially lower than noninfected cell lines, with 
phenotypic markers characteristic of similar (Fig. 2 a, lane A) and more immature 
(lane F) T  cells. A  Northern blot of three HTLV-l-infected cell lines hybridized 
with the TCRfl gene probe is shown  in  Fig.  2 b.  In lane G, showing  RNA from 388  T  CELL  RECEPTOR  /3  CHAIN  IN  HTLV-I-INFECTED CELLS 
FIGURE 3.  Comparison of the configuration of the TCRB gene in cloned T cells before and 
after infection by HTLV-I. 10 ttg of the indicated  DNA were digested with Hind lII (lanes 
A-C), Barn HI (D-F),  or Eco RI (G-/) and subjected to Southern blot analysis using the TCRI3 
gene clone YTJ2 as probe. The DNA was from CR-B, showing the germline configuration of 
the TCR/3 gene (A, D, and G), clone YTA1 (B), YTA1-H  (C), clone TM3 (E), TM3-H (F), 
clone TM5 (H), and TM5-H (/). 
the noninfected T  cell line RPMI 8402,  an intense band is seen at  1.3  kb, and a 
faint  band  is  detectable  at  1.0  kb.  In  contrast,  in  Fig.  2b,  lanes I-K,  showing 
RNA  from HTLV-I-infected cell  lines,  the  band at  1.3  kb is  less intense.  This 
supports the dot blot analysis and  is consistent  with  these cells being mature T 
cells. In lane I, showing RNA from HUT  102, a  band of similar intensity to the 
!.3 kb band is seen at  1.0  kb. This most probably represents a  transcript lacking 
a  V  region, and is an unexpected finding in a  mature T  cell. 
The  patterns  of  rearrangement  and  expression  of  the  TCR¢/  gene  were 
compared in  well-characterized T  cell clones before and after in vitro infection 
by HTLV-I to correlate any changes with alterations in immune function. YTA1, 
TM3, and TM5 are T  cell clones of helper-inducer  phenotype that are specific 
for  tetanus  toxoid.  They  display  the  following  surface  phenotype:  OKT4 +, 
OKT3 +, OKT8-,  HLA-DR  +, and  Tac-antigen +.  Following in  vitro infection by 
HTLV-I, clone  YTA1  (now  called  YTAI-H) lost  the  requirement  of accessory 
cells for proliferation  in  response to tetanus toxoid (12).  After a  longer time in 
culture,  this T  cell clone proliferated spontaneously and lost all antigen-specific 
responsiveness.  Clones  TM3-H and  TM5-H  were unable to respond to specific 
antigen  a  short  time after infection  by HTLV-I  (data  not  shown).  In addition, 
TM3-H  and  TM5-H  appeared  to  react  nondiscriminatively  to  HLA  class  II 
antigens (our unpublished observations). Fig. 3 shows a comparison of the TCR/3 
gene rearrangements before and after infection by HTLV-I. In DNA from each 
clone an additional band is seen relative to the germline configuration, when the JARRETT  ET  AL.  389 
FIGURE 4.  Comparison of expression of the TCRfl gene mRNA in cloned T  cells before and 
after infection by HTLV-I. (a) Dot blot analysis. RNA solutions were spotted in vertical rows 
using twofold  serial dilutions.  The  filter was  hybridized with  the s2P-nick-translated probe 
YTJ2 insert, which contains both C and V regions of the TCRfl gene. RNA was quantitated 
relative to hybridization with the HLA class I  gene pDPO.  The RNA was from clone TM3 
(lane A), clone TM3-H (B), clone TM5 (C), clone TM5-H (D), and PHA-stirnulated lyrnphocytes 
as a control (E). (b) Northern blot analysis. ~ 10 vg of total cellular RNA from the indicated T 
cell  clones  were  subjected  to  Northern  blot  analysis  using  YTJ2  insert as  probe.  Arrows 
indicate the positions of the 28 S and 18 S markers. The RNA was from TM3 (lane A), TM3- 
H (B), TM5 (C), and TM5-H (D). 
appropriate restriction enzyme is used; this implies rearrangement  of the TCRfl 
gene.  No  difference  in  the  pattern  of bands  is  detectable  after  infection  by 
HTLV-I. A comparison of the levels of expression of TCRfl RNA in clones TM3 
and TM5 pre- and postinfection is shown in Fig. 4a. After infection, expression 
appears  reduced  by approximately  twofold relative  to the expression  of HLA 
class  I  genes;  it  is  unlikely  that  this  represents  a  significant  decrease.  Fig.  4b 
shows a  Northern  blot analysis of RNA  from  the  same  T  cell  clones.  In  the 
uninfected clone TM3, transcripts of 1.3 and  1.0 kb are present. After infection, 
both mRNA species are transcribed,  but the  1.0 kb transcript appears relatively 
more abundant.  In  the  uninfected  clone TM5,  only the  full-length  mRNA  is 
detectable; however, after infection by HTLV-I, both transcripts  are visualized 
at roughly equal intensity. 
Surface expression of the T3  complex in  these T  cell clones was studied by 
FACS analysis,  as this complex of glycoproteins is stoichiometrically expressed 
with and noncovalently linked to the TCR on the surface of immunocompetent 
T  cells (21-24,  28).  Expression  of T3  molecules by infected cells was at  least 
74%  of that  of the  uninfected  cells  of the  same  lineage  when  compared  by 
median fluorescence intensity (Fig. 5), A small percentage of cells within each of 
the  infected  cell  populations  had  a  reduced  density  of surface  T3  molecules, 
which  resulted  in  a  slight  splaying  of the  fluorescence  profile  relative  to  the 
homogeneous T3 expression observed in the uninfected counterparts.  Infected 
cells also retained their expression of the T4 surface determinant. 
The configuration of the TCRfl gene in fresh tumor cells from ATLL patients 390  T  CELL  RECEPTOR  ~  CHAIN  IN  HTLV-I-INFECTED  CELLS 
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FIGURE  5.  The  effect  of HTLV-I  infection  on  the expression  of cell  surface  T3  and  T4 
determinants  was analyzed  by  indirect  immunofluorescence  and  flow  cytometry.  Cell  lines 
TM3,  TMf,  and YTA1  were either  uninfected  (-) (a-c, g-i) or infected (+) (d-f, j-l) with 
HTLV-I and stained for reactivity with antibodies OKT3 (a-f) or OKT4 (g-l) (solid lines). As 
a  negative  control,  unreactive  mouse  ascites was substituted  for  primary  antibody  (broken 
lines).  Fluorescence  intensity  is  plotted  on  a  logarithmic  scale  (abscissa),  and  the  ordinate 
represents cell number. 
was compared with the configuration in the cell lines subsequently established in 
culture. The first two examples, CF and HLS, have been the subjects of previous 
reports (50,  56).  The cell  lines established  from these cases are unusual in that 
they have surface markers characteristic of B cells. In both, DNA from the fresh 
tumor cells (Fig.  6) shows a clonal pattern of rearrangement  of the TCR gene, 
indicated by the appearance  of additional fragments and loss of germline  frag- 
ments. However, the configuration of the TCR/3 gene in the derived cell lines is 
identical to that of the germline configuration,  consistent with these cells being 
of B celt origin as previously documented (50, 56). In Fig. 6, lanes g-t, showing 
a Southern blot analysis of DNA from patient SK, both the fresh tumor cells and 
the  autoiogous cell  line  have  clonal  patterns  of rearrangement  of the  TCR~ 
gene. The single rearranged fragment in DNA from the primary tumor cells is 
of a  different  size  from  the  two additional  fragments  seen  in  DNA  from  the 
derived cell  line, indicating that the TCR¢~ rearrangements  that have occurred 
in these two cell populations are distinct. This strongly suggests that the cell line 
did not arise  from the primary  tumor cells.  Again,  from this data one cannot 
exclude  the possibility  that further  rearrangements  occurred  in culture,  but a JARRETT  ET  AL.  391 
FIGURE 6.  Comparison of the rearrangement of the TCR/3 gene in primary tumor cells and 
derived cell lines.  20 •g  of the indicated  DNA were digested with Hind  III (lanes A-C) or 
Barn HI (D-L) and analyzed by Southern blotting using the TCRfl gene clone YTJ2 insert as 
probe. The DNA was from CF-B, showing the germline configuration of the TCR/3 gene, (A), 
CF-fresh (B), CF-2 (C), CR-B again showing the germline configuration (D,  G, and J),  HLS- 
fresh (E), HLS-line (F), SK-fresh (H), SK-line (/),  SD-fresh (K), and SD-line (L). 
comparison of proviral integration  sites in these cells is more consistent with the 
former interpretation  (57). 
Patient SD (Fig. 6 d) was of particular interest because karotypic analysis of the 
fresh tumor cells revealed a tandem duplication of the long arm of chromosome 
7 (58, 59). The TCRfl gene has been mapped to chromosome 7 (60); conflicting 
reports have placed the gene variously on the long and the short arm (61, 62). 
Southern blot analysis following Bam HI digestion of DNA from primary tumor 
cells reveals the presence of two rearranged  bands,  in addition  to the germline 
bands. This suggests that at least three differently arranged alleles of the TCR/3 
gene are present in  the tumor cells. The cell  line established from this patient 
has a normal karyotype and a TCRfl gene rearrangement,  with evidence of only 
two alleles,  which  is different  from  that  seen in  the primary tumor cells.  This 
again implies that the cell line was not derived from the primary tumor cells. 
The configuration of the TCRfl gene in DNA from fresh neoplastic cells from 
four patients  with ATLL is shown in the above comparison (Fig.  6,  lanes B, E, 
H, and L), and one additional case, F9164, was also studied (data not shown). In 
each case, rearrangement  of the TCRfl gene is indicated by the loss of germline 
fragments and the presence of additional rearranged fragments. The tumor cells 
appear cional with respect to TCR/3 gene rearrangement  in all digestions, and 
no common pattern of rearrangement  is observed. 
Discussion 
The mechanism of transformation  by HTLV-I is unknown. The viral genome 
does not contain  an  oncogene of cellular  origin  and  there  is no evidence that 
promoter-enhancer  insertion  is  operative  in  this  disease,  as  integration  of the 
virus does not seem to occur at a specific site in the host cell DNA. It has been 
postulated that  the product of the x-lor gene at the 3' end of the viral genome 
acts  by  trans-acting  transcriptional  activation  of  viral  and  cellular  genes,  in 
particular genes that are specific for T  cell maturation and proliferation (63). In 
this study, we found that the full length TCR/~ mRNA was transcribed at similar 392  T  CELL  RECEPTOR  ¢3  CHAIN  IN  HTLV-I-INFECTED  CELLS 
or slightly lower levels by HTLV-I-infected cell lines than  by PHA-stimulated 
lymphocytes; this suggests that  this T  cell-specific gene is not transcriptionally 
activated or significantly depressed, as a result of HTLV-I infection. 
Infection by HTLV-I in vitro results in a variety of abnormalities of immune 
function, including impairment of the response to specific antigen and acquisition 
of alloreactivity. Levels of TCR/3 gene mRNA and surface T3 expression do not 
appear significantly altered after HTLV-I infection. Taken together, these data 
suggest that the number of TCR molecules on the cell surface is not appreciably 
changed after HTLV-I infection. Weiss and Stobo (64) have recently described 
a mutagenized Jurkat clone that expressed approximately one-tenth the density 
of TCR and T3 determinants expressed by the wild type Jurkat.  Despite this, it 
could be activated to levels comparable to those observed in the wild type Jurkat 
cells by both anti-T3 and ctonotypic antibodies, and also by PHA plus PMA. It 
is unlikely,  therefore,  that  a  subtle change  in the number  of TCR on the cell 
surface could account for loss of antigen-specific responsiveness. Thus, alterations 
in immune function in  HTLV-I-infected cells must be due either to structural 
changes  in  the  TCR-T3  complex or  to altered  expression  of other  molecules 
involved in the response to antigen.  Comparison of the TCR/3 gene configura- 
tions before and after HTLV-I infection does not reveal any changes detectable 
by Southern blot analysis. We cannot exclude the possibility that somatic muta- 
tions have occurred within the/3 chain gene or that changes have occurred within 
the  a  chain  gene.  It  has  been  previously reported  (65)  that  loss and  gain  of 
alloreactivity, among clones derived from a  T  cell hybridoma, were associated 
with structural changes in both a and/3 chains of the TCR, even though Southern 
blot analysis of the/3 chain gene did not detect any differences. It is possible that 
similar  sorts of somatic  mutation,  resulting  in  structural  changes  in  the  TCR 
which are not detectable at the level of Southern blotting, occur after HTLV-I 
infection. 
The appearance of the  1.0 kb TCR/3 transcript,  in addition to the full length 
mRNA in clone TM5-H is an intriguing finding. There is no evidence that this 
mRNA is translated,  and it may simply represent a  transcript  from a  nonfunc- 
tional  rearrangement  of the  TCR/3 gene.  However, after infection,  this  clone 
appears  to be nondiscriminatively  alioreactive,  as does the  cell  line  HUT102, 
which  also  expresses  the  truncated  message.  One  could  speculate  that  the 
encoded peptide chain forms part of a receptor complex capable of binding to a 
common structural determinant on HLA class II genes. Also, this transcript may 
represent a gene that is transcriptionally activated by the viral x-lor gene product. 
We have studied the configuration  of the  gene encoding the TCR/3 gene in 
the primary tumor cells from five cases of ATLL, and in 26 cell lines infected 
by HTLV-I,  12  of which  are  shown  in  this  report.  In  all  of these,  with  the 
exception  of  two  cell  lines  that  have  B  cell  markers,  the  TCR/3  gene  was 
rearranged.  In most of the cell lines and in all of the fresh tumor cells examined, 
the  cell  populations  appeared  clonal  with  respect to a  particular  TCR/3 gene 
rearrangement.  All  of the primary  tumor cells and  cell  lines established  from 
ATLL cases differed in the configuration of the TCR/3 gene. This suggests that 
at least the final  clonal expansion of T  cells associated with transformation  by 
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Studies  on  TCR  gene  rearrangements  provide a  unique  way of identifying 
individual  T  cells.  We  used  this  property  to  compare  primary  leukemic  cells 
from ATLL patients with the cell lines that were subsequently established from 
them.  Our  finding  that,  in  all  of  the  instances  examined,  the  TCR/3  gene 
rearrangements  in the primary cells were different from those in the cell lines 
suggests that  the cells that  grow out in culture are often, perhaps  usually,  not 
the original neoplastic cell. This extends previous studies (58, 60) that compared 
proviral integration sites and karyotypic abnormalities between primary cultures 
and derived cell lines.  It is possible that the transformed cells that grow out in 
culture become infected by HTLV-I in vitro, and that recent infection by HTLV- 
I confers a growth advantage over the cells previously infected in vivo. 
SD is particularly  interesting  in  that  the primary  tumor cells had  a  tandem 
duplication of the long arm of chromosome 7 and evidence of three differently 
arranged  alleles of the TCR/3 gene on Southern  blot analysis.  The latter result 
can be interpreted  in several ways. (a) The fresh tumor cells may be a  biclonal 
population of cells, with two distinct TCR/3 gene rearrangements.  (b) A  second 
TCR/3 gene rearrangement may have occurred during proliferation of the tumor 
cells in vivo. (c) A chromosomal break may have occurred within the TCR/3 gene. 
(d) The tandem duplication of the long arm of chromosome 7 may have resulted 
in the presence of three alleles of the TCR/3 gene. The last interpretation  seems 
most likely in view of the karyotypic abnormality, the intensity of the bands seen 
on Southern blot analysis, and the presence in these cells of a single integrated 
provirus  (data  not  shown).  If this  is  indeed  the  case,  the  presence  of three 
differently arranged TCR/3 genes suggests that the tandem duplication preceeded 
TCR/3 gene rearrangement.  This chromosomal abnormality was not present in 
all  of the  patient's  T  cells,  since  the  T  cell  line  established  in  culture  had  a 
normal  karyotype (59). Chromosomal abnormalities are demonstrable in nearly 
every case of ATLL; chromosome 7 is one of the chromosomes most frequently 
involved, but no consistent alterations have emerged (58, 59, 66). Nowell et al. 
(59) postulated  that  a  chromosomal  change  is not a  required early step in  the 
pathogenesis of ATLL, but may be involved in later stages of tumor progression. 
If this is true in the case of SD, then it would imply that not only the chromosomal 
change  but also the  initiation  of the malignant  process, which is likely to be a 
result of infection by HTLV-I, occurred before TCRB gene rearrangement,  at 
an early stage of T  cell maturation.  Since fresh and cultured cells from patients 
with ATLL, and umbilical cord blood cells infected by HTLV-I are T4 +, it has 
been suggested that the in vivo transformation process occurs in mature periph- 
eral  blood cells (67).  However, Markham  et al.  (67) showed that  bone marrow 
cells lacking the T4 and T8 phenotype, i.e., more immature cells, can be targets 
for transformation  by HTLV-I.  It  is  possible, and  in  keeping  with  the  above 
data,  that  the  infective process involves an  immature  cell,  which  subsequently 
rearranges its TCR genes, matures, and expresses the more commonly observed 
phenotype. 
The receptor-mediated  theory of leukemogenesis proposes that the envelope 
of slowly transforming retroviruses interacts with immunospecific receptors and/ 
or growth  factor receptors on  the surface of B and  T  cell neoplasms to cause 
continued cell division (68). If this were applicable to HTLV-I-associated malig- 394  T  CELL  RECEPTOR  fl  CHAIN  IN  HTLV-I-INFECTED  CELLS 
nancies and  the TCR molecule, one might expect to find a  limited number of 
TCR gene arrangements  in  cells infected by HTLV-I.  All of the  fresh tumor 
cells and cell lines established from the ATLL cases we examined had distinct 
TCR~ gene configurations. This result implies that infected cells can have a very 
large  number  of different  TCRfl gene  rearrangements,  and  makes the above 
hypothesis unlikely in the case of ATLL. However, since the TCR most probably 
has the capacity to recognize both foreign antigen and self HLA determinants, 
differences in  gene rearrangement  may reflect differences in  HLA restriction 
and  not simply different antigenic  specificities. Therefore,  we cannot  exclude 
the possibility that  all  of the TCR gene  rearrangements  described here  might 
result in a  molecule capable of binding  to determinants  on the viral envelope, 
although the extent of these differences makes this seem unlikely. 
Several aspects of the role of the TCR in alterations of immune function after 
HTLV-I infection and in transformation  by HTLV-I remain  speculative. How- 
ever, several facts have emerged.  There  is not a  restricted number of patterns 
of rearrangement  of the TCRfl gene associated with transformation  by HTLV- 
I. Expression of the full length TCRfl mRNA is not significantly altered in cells 
transformed  by HTLV-I.  Cell  lines  derived  from  the  leukemic  blood cells of 
ATLL patients  are  frequently,  and  perhaps  always, different  from  the  actual 
leukemic  cells.  We  hope  that  future  studies  will  shed  light  on  the  molecular 
events that lead to changes in immune function after infection by HTLV-I. 
Summary 
We studied the configuration and expression of the gene encoding the fl chain 
of the T  cell receptor (TCR~) in cell lines and primary tumor cells infected by 
the human  T  cell leukemia/lymphoma (lymphotrophic) virus type I  (HTLV-I). 
Most of the cell lines and all the primary tumor cells showed rearrangement  of 
the TCRfl gene, and in each case the rearrangement  was distinct. The majority 
of cases examined were clonal with respect to a particular TCRfl gene rearrange- 
ment.  Primary  tumor cells from  one case (SD) were found to  have a  tandem 
duplication of a portion of chromosome 7;  this appears to have resulted in the 
presence of three alleles of the TCR/3 gene, each of which is arranged differently. 
This  suggests  that  the  chromosomal  abnormality,  and  possibly  infection  by 
HTLV-I,  occurred  before TCRfl  gene  rearrangement.  Cell  lines  infected  by 
HTLV-I express levels of TCRfl mRNA similar to PHA stimulated lymphocytes, 
suggesting that this gene is not transcriptionally activated as a result of infection 
by HTLV-I. 
Cloned T  cells of known antigen  specificity that are  infected by HTLV-I  in 
vitro  show  impairment  of immune  function,  including  loss of antigen-specific 
responsiveness and the acquisition of alloreactivity. Comparison of the configu- 
ration of the TCR~ gene before and after infection revealed no changes detect- 
able by Southern  blot analysis.  Levels of expression of the TCRfl gene  at  the 
mRNA level and surface expression of the T3 complex were also not significantly 
altered,  suggesting  that  changes  in  immune  function  cannot  be attributed  to 
quantitative changes in the TCR molecule. 
The  configuration  of the  TCR/3  gene  in  primary  tumor  cells  infected  by 
HTLV-I was compared with that in the derived cell lines. In all pairs examined, JARRETT  ET  AL.  395 
the configuration  in the primary tumor cells was different from that  in the cell 
lines, strongly suggesting that the cells that grow in culture are not the original 
neoplastic cells. 
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